MiR-614 was found to inhibit cell proliferation [49], CHD4 regulates both proliferative and migratory abilities of NSCLC cells via the RhoA/ROCK pathway [50], while the role of DPY30 has not yet been clarified in lung cancer (Figure 2b). Here, RHOA is linked to lung cancer.